Company CVAbout Dr Reddys Laboratories Ltd 
Dr Reddys Laboratories Ltd
Large Cap
Pharmaceuticals & Drugs
Dr Reddy's Laboratories Limited (DRL) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services &Active Ingredients, Global Generics and Proprietary Products - Dr. Reddy's offers a portfolio of products and services including Active Pharmaceutical Ingredients (APIs), custom pharmaceutical services, generics, biosimilars and differentiated formulations.
Company Coordinates
Company Details
8-2-337 Road No 3, Banjara Hills Hyderabad Telangana : 500034
Registrar Details
Bigshare Services Pvt Ltd , 306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital, Raj Bhavan Road, Somajiguda, Hyderabad
Capital StructureCapital Structure
Present Equity Capital
INR 83.44 Cr
Number of Shares
83.44 Cr
Face Value
INR 1.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
28-Oct-2024
83.44
83.44
667507784
1
Stock Split
21-Sep-2024
16.69
83.44
7064
5
Issued under ESOP Scheme
29-Aug-2024
16.69
83.43
10391
5
Issued under ESOP Scheme
07-Aug-2024
16.69
83.43
29790
5
Issued under ESOP Scheme
14-Jun-2024
16.68
83.41
5332
5
Issued under ESOP Scheme
02-Jun-2024
16.68
83.41
6103
5
Issued under ESOP Scheme
14-Mar-2024
16.68
83.41
5116
5
Issued under ESOP Scheme
22-Feb-2024
16.68
83.41
3753
5
Issued under ESOP Scheme
09-Dec-2023
16.68
83.40
9181
5
Issued under ESOP Scheme
21-Nov-2023
16.68
83.40
3362
5
Issued under ESOP Scheme
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
FIIs
Pledged Promoter Holdings
None
Mutual Funds
Held by 37 Schemes (11.14%)
FIIs
Held by 828 FIIs (26.85%)
Promoter with highest holding
G V Prasad (11.52%)
Highest Public shareholder
J P Morgan Chase Bank Na (13.23%)
Individual Investors Holdings
8.07%
Board of Directors
Management
Designation
Remuneration
G V Prasad
Co-Chairman & Managing Directo
18.77 cr
K Satish Reddy
Executive Chairman
11.54 cr
Kalpana Morparia
Independent Director
1.53 cr
Shikha Sanjaya Sharma
Independent Director
1.31 cr
Leo Puri
Independent Director
1.53 cr
K P Krishnan
Independent Director
1.32 cr
Pennv Wan
Independent Director
1.69 cr
K Randhir Singh
Company Sec. & Compli. Officer
0
Arun M. Kumar
Independent Director
1.09 cr
Claudio Albrecht
Independent Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Purchase of Traded Goods
1779.3
0%
Purchase of Traded Goods
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharmaceuticals
10,466.70
98.51%
License Fees
55.90
0.53%
Service Income
50.30
0.47%
Pharmaceuticals
Pharmaceuticals
License Fees
License Fees
Service Income
Service Income
Stock DNARevenue and Profits:
Net Sales:
8,381 Cr
(Quarterly Results - Dec 2024)
Net Profit:
1,414 Cr
Pharmaceuticals & Drugs
INR 93,747 Cr (Large Cap)
17.00
33
0.73%
-0.01
17.36%
2.97
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
